Thought Participation: Why Most Healthtech Thought Leadership Isn't Leadership

Most healthtech thought leadership isn't leadership. It's participation with a byline. That's what healthtech marketing leaders are saying about themselves.

This month we ran two candid peer sessions on thought leadership in the Healthtech Marketing Network, and this solo episode is my report on what came out of them. When we asked senior marketing leaders where their programs sit on Adrianna Hosford's three levels of thought leadership, almost everyone said level two. A few said zero. Not one person claimed level three, even though industry surveys say 97% of practitioners believe their programs deliver measurable impact.

I walk through six themes from those conversations. Why evidence alone is not a point of view. Why the bar for bold is lower in healthcare than you think. Why your best thought leader might be a director, a clinician, or a KOL rather than your CEO. How AI went from a bad author to your most important reader. Why the stage is the source and everything else is the echo. And why the attribution ceiling is starting to crack. Along the way I bring in insights from past guests Adrianna Hosford, Paul Wicks, and John Lynn, and I close with five takeaways and one exercise you can try this week.

If you've ever wondered whether your thought leadership actually sets you apart or just adds to the noise, this episode will help you find out.

Key Topics Covered:

• "(00:00)" Introduction
• "(03:10)" Adrianna Hosford's three levels of thought leadership
• "(06:00)" The level two trap: free education for your whole category
• "(07:00)" Evidence is not a point of view
• "(08:45)" Two CEOs who paired proof with a real opinion
• "(10:10)" Regulatory constraints and healthcare's lower bar of controversy
• "(12:25)" KOLs as third-party endorsement
• "(13:25)" Building thought leadership for buying committees
• "(15:05)" AI as author: why it produces the generic average
• "(17:00)" AI as audience: what LLMs weigh when deciding who gets cited
• "(18:10)" John Lynn's counterpoint on branded content and AI citations
• "(19:25)" Why conferences and live events came out on top
• "(20:15)" Why the room was skeptical of LinkedIn despite the ROI data
• "(21:20)" Podcasting as the bridge between the live moment and the long tail
• "(22:30)" Can thought leadership be tied to pipeline?
• "(25:25)" Five key takeaways
• "(27:05)" One thing to try this week
• "(27:25)" Closing thoughts

Previous Episodes Mentioned:

• Is Sponsored Media as Trusted as Earned Media?
• The Thought Leadership Gap in Healthtech
• How to Build Pipeline With Podcasts
• How Peer-Reviewed Evidence Drives AI Discoverability

Resources Mentioned:

• Thought Leadership in Practice: The 2026 Report
• The ROI of Thought Leadership: Calculating the Value that Sets Organizations Apart

If you are interested in discussing this or any other topic, let's have a chat.  Reach out to me directly to schedule a no-obligation discussion. This isn't a sales call, but rather an opportunity to talk through your questions and challenges.

Follow me on LinkedIn.

Subscribe to The Healthtech Marketing Show on Spotify or watch us on YouTube for more insights into marketing, AI, ABM, buyer journeys, and beyond!

Find all of our episodes on the Health Podcast Library.

Thank you to our presenting sponsor, HealthcareNOW, 24/7 expert shows, interviews, and podcasts, powering healthcare leaders with innovation, policy, and strategy insights.